Table 6.
Average Inputs | Average Outputs | |||||||||||||
Global Output | Count | ECM | EGF | ExtPump | alpha_q Ligand | alpha_i Ligand | alpha_s Ligand | alpha_12_13 Ligand | IL1_TNF | Stress | Akt | Erk | Cdc42 | Rac |
2200 | 229 | 39 | 62 | 37 | 51 | 50 | 49 | 51 | 2 | 2 | 49 | 79 | 4 | 3 |
2211 | 172 | 83 | 46 | 42 | 46 | 48 | 45 | 52 | 2 | 2 | 42 | 75 | 18 | 15 |
2210 | 153 | 55 | 69 | 53 | 51 | 52 | 51 | 49 | 2 | 2 | 48 | 82 | 15 | 5 |
1000 | 142 | 19 | 23 | 64 | 51 | 46 | 47 | 45 | 2 | 2 | 19 | 3 | 1 | 1 |
2000 | 75 | 11 | 62 | 44 | 54 | 54 | 50 | 56 | 1 | 2 | 42 | 3 | 0 | 0 |
1211 | 45 | 87 | 24 | 71 | 48 | 46 | 53 | 54 | 2 | 2 | 23 | 63 | 16 | 19 |
2100 | 32 | 13 | 78 | 61 | 49 | 51 | 48 | 51 | 3 | 2 | 49 | 15 | 1 | 0 |
2201 | 28 | 83 | 46 | 22 | 46 | 56 | 51 | 57 | 2 | 2 | 46 | 76 | 6 | 14 |
1200 | 25 | 41 | 27 | 77 | 48 | 50 | 43 | 47 | 2 | 2 | 22 | 61 | 5 | 4 |
1201 | 21 | 75 | 9 | 65 | 57 | 48 | 46 | 47 | 2 | 2 | 21 | 58 | 5 | 17 |
1210 | 16 | 54 | 37 | 83 | 48 | 61 | 38 | 50 | 2 | 2 | 23 | 64 | 14 | 6 |
2221 | 13 | 89 | 68 | 57 | 43 | 35 | 53 | 49 | 2 | 1 | 46 | 79 | 32 | 15 |
1001 | 6 | 58 | 11 | 49 | 43 | 26 | 52 | 53 | 1 | 3 | 16 | 1 | 5 | 11 |
2220 | 5 | 79 | 92 | 86 | 39 | 82 | 33 | 45 | 3 | 2 | 57 | 88 | 32 | 8 |
1100 | 5 | 32 | 12 | 46 | 45 | 65 | 44 | 57 | 2 | 2 | 22 | 18 | 6 | 4 |
1011 | 4 | 66 | 13 | 71 | 24 | 33 | 60 | 45 | 2 | 2 | 14 | 2 | 19 | 14 |
1010 | 4 | 50 | 14 | 88 | 63 | 66 | 46 | 62 | 1 | 2 | 15 | 1 | 16 | 7 |
2110 | 3 | 36 | 35 | 29 | 31 | 64 | 55 | 55 | 3 | 1 | 34 | 18 | 11 | 5 |
1212 | 2 | 95 | 4 | 50 | 40 | 65 | 68 | 91 | 2 | 1 | 23 | 56 | 12 | 31 |
1110 | 2 | 60 | 39 | 84 | 71 | 61 | 26 | 81 | 5 | 3 | 23 | 19 | 19 | 8 |
0011 | 2 | 67 | 1 | 91 | 54 | 5 | 46 | 74 | 2 | 4 | 8 | 2 | 10 | 17 |
1202 | 2 | 90 | 5 | 61 | 68 | 53 | 41 | 51 | 2 | 4 | 19 | 57 | 9 | 30 |
1111 | 2 | 67 | 16 | 100 | 55 | 89 | 80 | 20 | 2 | 3 | 13 | 16 | 24 | 15 |
0001 | 1 | 71 | 0 | 64 | 68 | 4 | 97 | 69 | 5 | 1 | 8 | 5 | 6 | 17 |
0100 | 1 | 47 | 16 | 100 | 31 | 13 | 1 | 85 | 3 | 5 | 9 | 15 | 4 | 6 |
0201 | 1 | 92 | 3 | 100 | 73 | 92 | 85 | 82 | 2 | 5 | 5 | 53 | 6 | 29 |
2212 | 1 | 99 | 15 | 47 | 59 | 24 | 32 | 17 | 4 | 0 | 34 | 64 | 23 | 30 |
0010 | 1 | 29 | 20 | 98 | 73 | 7 | 71 | 63 | 1 | 5 | 7 | 1 | 11 | 3 |
1002 | 1 | 98 | 3 | 58 | 43 | 5 | 59 | 70 | 5 | 3 | 13 | 5 | 9 | 33 |
1221 | 1 | 100 | 38 | 87 | 95 | 40 | 79 | 51 | 0 | 1 | 23 | 69 | 33 | 26 |
1021 | 1 | 81 | 23 | 88 | 73 | 10 | 78 | 22 | 1 | 0 | 15 | 1 | 34 | 21 |
0212 | 1 | 100 | 9 | 99 | 62 | 54 | 19 | 3 | 5 | 1 | 9 | 57 | 17 | 34 |
2111 | 1 | 50 | 14 | 24 | 41 | 90 | 22 | 32 | 3 | 0 | 31 | 27 | 18 | 10 |
0202 | 1 | 100 | 4 | 90 | 41 | 49 | 39 | 48 | 5 | 5 | 9 | 55 | 2 | 33 |
0211 | 1 | 75 | 9 | 96 | 80 | 91 | 95 | 21 | 1 | 3 | 8 | 57 | 11 | 17 |
Similarly to Table 5, results summarized in this table were generated during an experiment consisting of 1,000 simulation with the same paremeters (e.g., all dosages were selected randomly in a stress limited environment, discretization, etc.). Contrary to the simulation from Table 5 however, in this example, cells were simulated with constitutively active Ras. Results of this experiment show a marked increase in Erk activity (as has been suggested by laboratory research, [24,25]), simulating a growth-factor independent activation of Erk. This phenomena can be easily seen either in the Global Output and Count columns where 229 of the 1,000 simulations produced the '2200' pattern (global output) and over 500 simulations resulted in '22XX' or the Average Output column which shows that the majority of external-input combinations resulted in Erk average activity of 75–82%.